Abstract:Rationale In pulmonary arterial hypertension (PAH), highly proliferative microvascular endothelial cells (MVECs) are thought to contribute to vaso‐occlusive lesion formation and increased pulmonary artery pressures. Using MVECs isolated from the Sugen/Hypoxia (SuHx) model of PAH, we recently showed that increased mtROS production activates the transient receptor potential vanilloid‐4 (TRPV4) channel and contributes to increased MVEC proliferation in vitro . However, the mechanistic basis for sustained mtROS production in MVECs isolated from SuHx rats (SuHx‐MVECs) was unclear. Along with increased mtROS production, we observed evidence of significant mitochondrial dysfunction, including increased fragmentation and glycolytic shift. Since mtROS production can be regulated by shifts in TCA fuel substrates, we hypothesized that generation of TCA metabolites using non‐glucose sources (i.e. anaplerosis) could be the source of mitochondrial dysfunction and mtROS production in SuHx‐MVECs. Methods Ca 2+ was measured using Fura‐2AM loaded MVEC in a flow chamber perfused with Krebs buffer. Mitochondrial morphology was measured computationally using previously validated algorithms applied to confocal images of mitochondria in N‐ and SuHx‐MVEC treated with MitoTracker. ROS measurements were made using the ratiometric ROS sensor roGFP. Lipid droplets were assessed using BODIPY staining in live MVECs, and quantified using CellProfiler. Targeted metabolomics were conducted using a standardized LC/MS approach and MS‐grade reagent standards. Results Despite evidence of glycolytic shift (decreased oxygen consumption rate, increased extracellular acidification rate, increased extracellular lactate levels), levels of TCA metabolites (measuring using targeted metabolomics) were not significantly lower in SuHx‐MVECs compared to normoxic (N‐MVEC) controls, suggesting presence of significant anaplerosis. Serum free fatty acids (FFA) were increased in SuHx rats at 5 weeks. Intracellular lipid droplet number was increased in SuHx‐MVECs, while droplet size was decreased, suggesting increased FA utilization. Untargeted metabolomics performed in N‐MVEC and SuHx‐MVEC cell extracts revealed evidence of metabolite shunting towards nucleotide and amino acid synthesis as well as increased levels of fatty acid oxidation byproducts. In cultured SuHx‐MVECs, inhibition of mitochondrial fatty acid import (with Etoximir) attenuated basal Ca 2+ and mitochondrial fragmentation to a similar extent as mtROS quenching and TRPV4 inhibition. Conclusion Increased utilization of fatty acid oxidation for anaplerotic carbons is associated with mitochondrial fragmentation and mtROS production, which in turn increases [Ca 2+ ] I via a TRPV4‐dependent mechanism. These data suggest a novel link between EC metabolism, mitochondrial dysfunction and TRPV4 activation in the SuHx model of PAH. Support or Funding Information This work was supported by by the National Heart, Lung and Blood Institute Grants F32HL124930 and K08HL132055 (KS), R01HL073859, R25HL084762 and R01HL126514 (LAS), F32HL124727, and K08HL133475 (JH) and T32HL007534 (KS and JH).

Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

Role of Mitochondrial Reactive Oxygen Species (ROS) and TRPV4 Activation in Microvascular Endothelial Cell Dysfunction in PAH.

Regulation of Mitochondrial Fragmentation in Microvascular Endothelial Cells Isolated from the SU5416/hypoxia Model of Pulmonary Arterial Hypertension.

Metabolic Regulation of Mitochondrial Reactive Oxygen Species (mtros) Production and Transient Receptor Potential Vanilloid‐4 (TRPV4) Activation in Microvascular Endothelial Cells in PAH

Mitochondrial ROS (mtros) Production and TRPV4 Translocation/activation in Lung Microvascular Endothelial Cells

Increased fatty acid oxidation promotes mitochondrial ROS (mtROS) production and Ca 2+ entry via TRPV4 in microvascular endothelial cells in PAH

Mitochondrial ROS Production in Lung Microvascular Endothelial Cells Sensitizes the Transient Receptor Potential Vanilloid‐4 (TRPV4) Channel to Physical and Chemical Stimuli.

Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells from the Rat SU5416/Hypoxia Model of Pulmonary Hypertension

Fatty Acid Metabolism Promotes TRPV4 Activity in Lung Microvascular Endothelial Cells in Pulmonary Arterial Hypertension.

Aquaporin 1 Mediates Microvascular Endothelial Dysfunction in the SU5416/hypoxia Model of Pulmonary Hypertension

Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension

The Na+/H+ Exchanger Contributes To Increased Smooth Muscle Proliferation And Migration In A Rat Model Of Pulmonary Arterial Hypertension

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

Reactive Oxygen Species Effect PASMCs Apoptosis Via Regulation of Dynamin-Related Protein 1 in Hypoxic Pulmonary Hypertension

Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension

Pulmonary Hypertension Induces Serotonin Hyperreactivity and Metabolic Reprogramming in Coronary Arteries via NOX1/4-TRPM2 Signaling Pathway

Involvement of Calcium-Sensing Receptors in Hypoxia-Induced Vascular Remodeling and Pulmonary Hypertension by Promoting Phenotypic Modulation of Small Pulmonary Arteries

Hypoxia-Induced Mitochondrial ROS and Function in Pulmonary Arterial Endothelial Cells

Metabolic reprogramming, oxidative stress, and pulmonary hypertension

Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

Abstract 9814: Nf-?B Inhibition Prevents Vascular Obliteration and Improves Immune Regulation in Severe Pulmonary Arterial Hypertension